Michael J Nugteren
Overview
Explore the profile of Michael J Nugteren including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
11
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wegerif E, Nugteren M, van Galen I, Hazenberg C, Schreve M, Akkersdijk G, et al.
J Endovasc Ther
. 2025 Jan;
15266028241312356.
PMID: 39840536
Objective: There is a lack of consensus regarding the optimal antithrombotic therapy (ATT) after popliteal and infrapopliteal (PIP) endovascular therapy (EVT). Currently, dual antiplatelet therapy (DAPT) for 3 months and...
2.
Nugteren M, Hazenberg C, Bakker O, Dinkelman M, Fioole B, Hinnen J, et al.
Eur J Vasc Endovasc Surg
. 2024 Sep;
69(2):304-312.
PMID: 39341420
Objective: The prevalence of chronic limb threatening ischaemia (CLTI) is increasing worldwide, resulting in the need for more patients to undergo revascularisation, especially for below the knee pathology. Nevertheless, prospective...
3.
Nugteren M, Unlu C, Samim M, Scheffer H, de Borst G, Hazenberg C
Cardiovasc Intervent Radiol
. 2024 Aug;
47(11):1441-1449.
PMID: 39187653
Purpose: Peripheral arterial calcification is an important predictor of outcomes after both conservative and endovascular treatment. Digital subtraction angiography (DSA)-based calcification scores are limited by low sensitivity and inter-observer agreement....
4.
Hoitz N, Nugteren M, Huizing E, Fioole B, Mees B, de Borst G, et al.
Ann Vasc Surg
. 2024 Jul;
110(Pt B):145-158.
PMID: 39009126
Background: To review the current literature and establish a consensual recommendation on duplex ultrasound (DUS) surveillance after endovascular treatment of the femoropopliteal tract. Methods: This systematic review conducted literature searches...
5.
Nugteren M, Hazenberg C, Akkersdijk G, van den Heuvel D, Schreve M, Unlu C
J Endovasc Ther
. 2023 Oct;
:15266028231205421.
PMID: 37853746
Purpose: Vessel calcification is estimated to be present in 30% to 50% of patients with peripheral arterial disease (PAD) and is one of the main challenges in endovascular treatment. The...
6.
Nugteren M, Hazenberg C, Akkersdijk G, Bakker O, Dinkelman M, Fioole B, et al.
PLoS One
. 2023 Jul;
18(7):e0288912.
PMID: 37471351
Introduction: Chronic limb-threatening ischemia (CLTI) is the end stage of peripheral arterial disease (PAD) and is associated with high amputation rates, mortality and disease-related health care costs. In infrapopliteal arterial...
7.
Nugteren M, Welling R, Bakker O, Unlu C, Hazenberg C
J Endovasc Ther
. 2022 Sep;
31(2):191-202.
PMID: 36062761
Purpose: Infrapopliteal lesions are generally complex to treat due to small vessel diameter, long lesion length, multilevel disease, and severe calcification. Therefore, different vessel preparation devices have been developed to...
8.
Nugteren M, de Borst G, van den Broek W, Ten Berg J, Kappelle L, Unlu C
Ned Tijdschr Geneeskd
. 2022 Jun;
166.
PMID: 35736355
The population of elderly with cardiovascular diseases and multimorbidity is rapidly growing. For decades, different antithrombotic therapies have been studied to find the most effective therapy in reducing the risk...
9.
Nugteren M, Catarinella F, Koning O, Hinnen J
Expert Rev Med Devices
. 2021 May;
18(7):581-586.
PMID: 34057375
Peripheral arterial disease (PAD) is an occlusive vascular disease of the lower extremities with increasing incidence and prevalence numbers and therefore rising health care costs. Mobile applications have great potential...